Request for Covid-19 Impact Assessment of this Report
The organ care system is cutting edge technology of medical which allows organ sustainability and artificial environment that simulates as normal human like state. This technology allows organs like liver, kidney, lung and others. This state-of-art-technology provides monitoring of liver during the whole process.
Aging population, obesity, heavy alcohol use are the factors which are responsible for rising incidence of chronic liver failure around the world. As per European Association for the Study of the Liver, Currently, cirrhosis is became the 11th frequent cause of death in the globe coupled with the cancer of liver is 16th leading cause of death cases. Moreover, DCD programs (Donation after Circulatory Death) initially focusing on liver retrieval and successful transplantation, identification of patients as potential DCD donor & minimization of consequences of warm ischemia. These key elements can incline the organ care system market share for liver. Cold ischemia time for liver is around 12 to 14 hrs. Therefore, considering the geographical factor, liver can travel farther than hearts and lungs.
Donor shortage for liver transplantation & socio-cultural, ethical and religious issues in organ donation such factors can hamper the OCS market for liver. According to OPTN data reports (July 2019), 11.6 % of liver disease cases are still on the waiting list for the transplantation of liver.
As per publication Brazilian Transplants Registry – ABTO Brazil ranks in the top five countries for the surgeries of liver transplantation. In addition, elements like enormous increase in transplantation centers resulting rise in the cases of liver transplantation as well as enhancement in program of living donors are estimated to drive the growth of organ care system market for liver. Aforementioned factors can create opportunities for the OCS Market for liver.
The trolley based organ care system for liver generated a revenue of $12.0 million in 2018, and it is projected to reach upto $22.4 million by the end of 2026.
Portable organ care system for liver was $9.1 million in 2018, and it is projected to reach upto $18.1 million by the end of year 2026. Portable organ care system for liver acquire less space and easy to handle. Also, due to newest advancements of cold storage in portable organ care system for liver expected to upsurge the global market.
North America market generated revenue of $8.9million by the end of 2018 and it is further anticipated to reach upto $19.1 by the 2026. In this region, organ care system market for liver is mainly led by the US. And Canada. As per researchers of UC san Francisco, Jan 2019, Alcohol-Related Liver Disease (ALD) is become most frequent reason for U.S liver transplants along with the number of liver transplants in US. Is doubled in the last 15 years. In addition, increased improvements in results of post transplantation is the major factor which can grow the market of organ care system for liver.
Asia-Pacific market for OCS market size for liver predicted to reach upto $6.0 Million by the end of year 2026. This is emerging market for organ care system for liver due to factors like western countries are more regulated, organized and have reached a plateau of transplant volume, whereas emerging nations of Asia-Pacific are less systematic and rising rapidly in both their capabilities and volumes. China, Taiwan, India are emphasizing on state of the art infrastructure with best surgeons, to reduction in surgical complications, advanced liver transplant facility & improvisation of safety of patient. Thus, in Asia-pacific region, it is estimated to drive the OCS liver market.
Key participants in Global Organ Care System Market for Liver:
Product development and joint ventures are the most common strategies followed by the market players
Source: Research Dive Analysis
The global organ care system for liver market key players include TransMedics Inc., Bridge to Life Ltd., Paragonix Technologies Inc. Preservation Solution Inc., Organ Transport System Inc., Preservation Solution Inc., XVIVO Perfusion AB, Organ Assist B.V., Organ Recovery Systems Inc., Water Medical System LLC, OrganOx Limited. These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development. For instance, XVIVO & MyCartis made alliance for the development of fast diagnostic test which is used to check the quality of donated organs.
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Mode of Handling
3. Market overview
3.1. Market segmentation & definitions
3.2. Key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Market value chain analysis
3.8.1. Stress point analysis
3.9. Strategic overview
4. Organ Care System Market for Liver, by Mode of Handling
4.1. Portable
4.1.1. Market size and forecast, by region, 2016-2026
4.1.2. Comparative market share analysis, 2018 & 2026
4.2. Trolley Based
4.2.1. Market size and forecast, by region, 2016-2026
4.2.2. Comparative market share analysis, 2018 & 2026
5. Organ Care System Market of Liver, by Region
5.1. North America
5.1.1. Market size and forecast, by type of handling, 2016-2026
5.1.2. Market size and forecast, by country, 2016-2026
5.1.3. Comparative market share analysis, 2018 & 2026
5.1.4. U.S.
5.1.4.1. Market size and forecast, by type of handling,2016-2026
5.1.4.2. Comparative market share analysis, 2018 & 2026
5.1.5. Canada
5.1.5.1. Market size and forecast, by type of handling,2016-2026
5.1.5.2. Comparative market share analysis, 2018 & 2026
5.1.6. Mexico
5.1.6.1. Market size and forecast, by type of handling,2016-2026
5.1.6.2. Comparative market share analysis, 2018 & 2026
5.2. Europe
5.2.1. Market size and forecast, by type of handling,2016-2026
5.2.2. Market size and forecast, by country, 2016-2026
5.2.3. Comparative market share analysis, 2018 & 2026
5.2.4. Germany
5.2.4.1. Market size and forecast, by type of handling,2016-2026
5.2.4.2. Comparative market share analysis, 2018 & 2026
5.2.5. Spain
5.2.5.1. Market size and forecast, by type of handling,2016-2026
5.2.5.2. Comparative market share analysis, 2018 & 2026
5.2.6. France
5.2.6.1. Market size and forecast, by type of handling,2016-2026
5.2.6.2. Comparative market share analysis, 2018 & 2026
5.2.7. Italy
5.2.7.1. Market size and forecast, by type of handling,2016-2026
5.2.7.2. Comparative market share analysis, 2018 & 2026
5.2.8. Rest of the Europe
5.2.8.1. Market size and forecast, by type of handling,2016-2026
5.2.8.2. Comparative market share analysis, 2018 & 2026
5.3. Asia-Pacific
5.3.1. Market size and forecast, by type of handling,2016-2026
5.3.2. Market size and forecast, by country, 2016-2026
5.3.3. Comparative market share analysis, 2018 & 2026
5.3.4. China
5.3.4.1. Market size and forecast, by type of handling,2016-2026
5.3.4.2. Comparative market share analysis, 2018 & 2026
5.3.5. Japan
5.3.5.1. Market size and forecast, by type of handling,2016-2026
5.3.5.2. Comparative market share analysis, 2018 & 2026
5.3.6. India
5.3.6.1. Market size and forecast, by type of handling,2016-2026
5.3.6.2. Comparative market share analysis, 2018 & 2026
5.3.7. Australia
5.3.7.1. Market size and forecast, by type of handling,2016-2026
5.3.7.2. Comparative market share analysis, 2018 & 2026
5.3.8. South Korea
5.3.8.1. Market size and forecast, by type of handling,2016-2026
5.3.8.2. Comparative market share analysis, 2018 & 2026
5.3.9. Rest of the Asia Pacific
5.3.9.1. Market size and forecast, by type of handling,2016-2026
5.3.9.2. Comparative market share analysis, 2018 & 2026
5.4. LAMEA
5.4.1. Market size and forecast, by type of handling,2016-2026
5.4.2. Market size and forecast, by country, 2016-2026
5.4.3. Comparative market share analysis, 2018 & 2026
5.4.4. Brazil
5.4.4.1. Market size and forecast, by type of handling,2016-2026
5.4.4.2. Comparative market share analysis, 2018 & 2026
5.4.5. Saudi Arabia
5.4.5.1. Market size and forecast, by type of handling,2016-2026
5.4.5.2. Comparative market share analysis, 2018 & 2026
5.4.6. South Africa
5.4.6.1. Market size and forecast, by type of handling,2016-2026
5.4.6.2. Comparative market share analysis, 2018 & 2026
5.4.7. Rest of LAMEA
5.4.7.1. Market size and forecast, by type of handling,2016-2026
5.4.7.2. Comparative market share analysis, 2018 & 2026
6. Company profiles
6.1. TransMedics Inc.
6.1.1. Business overview
6.1.2. Financial performance
6.1.3. Product portfolio
6.1.4. Recent strategic moves & developments
6.1.5. SWOT analysis
6.2. Bridge to life and Ltd.
6.2.1. Business overview
6.2.2. Financial performance
6.2.3. Product portfolio
6.2.4. Recent strategic moves & developments
6.2.5. SWOT analysis
6.3. Paragonix Technologies Inc.
6.3.1. Business overview
6.3.2. Financial performance
6.3.3. Product portfolio
6.3.4. Recent strategic moves & developments
6.3.5. SWOT analysis
6.4. Preservation Solution Inc.,
6.4.1. Business overview
6.4.2. Financial performance
6.4.3. Product portfolio
6.4.4. Recent strategic moves & developments
6.4.5. SWOT analysis
6.5. Organ Transport System Inc.
6.5.1. Business overview
6.5.2. Financial performance
6.5.3. Product portfolio
6.5.4. Recent strategic moves & developments
6.5.5. SWOT analysis
6.6. Preservation Solution Inc.
6.6.1. Business overview
6.6.2. Financial performance
6.6.3. Product portfolio
6.6.4. Recent strategic moves & developments
6.6.5. SWOT analysis
6.7. XVIVO Perfusion AB
6.7.1. Business overview
6.7.2. Financial performance
6.7.3. Product portfolio
6.7.4. Recent strategic moves & developments
6.7.5. SWOT analysis
6.8. Organ Assist B.V.
6.8.1. Business overview
6.8.2. Financial performance
6.8.3. Product portfolio
6.8.4. Recent strategic moves & developments
6.8.5. SWOT analysis
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...